- Home
- RUSHB vs HUMAW Comparison
RUSHB vs HUMAW Comparison
Compare RUSHB & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUSHB
- HUMAW
- Stock Information
- Founded
- RUSHB 1965
- HUMAW 2004
- Country
- RUSHB United States
- HUMAW United States
- Employees
- RUSHB N/A
- HUMAW 220
- Industry
- RUSHB Retail-Auto Dealers and Gas Stations
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- RUSHB Consumer Discretionary
- HUMAW Health Care
- Exchange
- RUSHB Nasdaq
- HUMAW Nasdaq
- Market Cap
- RUSHB N/A
- HUMAW N/A
- IPO Year
- RUSHB 1996
- HUMAW N/A
- Fundamental
- Price
- RUSHB $52.15
- HUMAW $0.55
- Analyst Decision
- RUSHB
- HUMAW
- Analyst Count
- RUSHB 0
- HUMAW 0
- Target Price
- RUSHB N/A
- HUMAW N/A
- AVG Volume (30 Days)
- RUSHB 23.4K
- HUMAW 14.2K
- Earning Date
- RUSHB 07-30-2025
- HUMAW 03-21-2025
- Dividend Yield
- RUSHB 1.39%
- HUMAW N/A
- EPS Growth
- RUSHB N/A
- HUMAW N/A
- EPS
- RUSHB 3.57
- HUMAW N/A
- Revenue
- RUSHB $7,783,577,000.00
- HUMAW N/A
- Revenue This Year
- RUSHB N/A
- HUMAW N/A
- Revenue Next Year
- RUSHB $9.87
- HUMAW N/A
- P/E Ratio
- RUSHB $13.45
- HUMAW N/A
- Revenue Growth
- RUSHB N/A
- HUMAW N/A
- 52 Week Low
- RUSHB $37.85
- HUMAW $1.18
- 52 Week High
- RUSHB $61.55
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- RUSHB 40.57
- HUMAW N/A
- Support Level
- RUSHB $51.03
- HUMAW N/A
- Resistance Level
- RUSHB $52.44
- HUMAW N/A
- Average True Range (ATR)
- RUSHB 1.17
- HUMAW 0.00
- MACD
- RUSHB -0.13
- HUMAW 0.00
- Stochastic Oscillator
- RUSHB 19.55
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.